Novavax (NVAX) Change in Cash (2010 - 2026)

Novavax's Change in Cash history runs 17 years deep, the most recent figure standing at -$23.1 million for Q1 2026.

• In Q1 2026, Change in Cash rose 91.33% year-over-year to -$23.1 million; the TTM figure through Mar 2026 stood at -$45.6 million (up 79.05% YoY), while the FY2025 annual figure was -$289.2 million, down 650.92% from the prior year.
• Change in Cash was -$23.1 million for Q1 2026 at Novavax, up from -$27.3 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $199.6 million in Q2 2024 to a low of -$711.9 million in Q1 2023.
• Historically, Change in Cash has averaged -$76.2 million across 5 years, with a median of -$43.3 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Change in Cash plunged 1374.87% in 2023, then jumped 267.75% in 2024.
• A 5-year view of Change in Cash shows it stood at $55.8 million in 2022, then tumbled by 247.88% to -$82.6 million in 2023, then surged by 47.55% to -$43.3 million in 2024, then surged by 36.93% to -$27.3 million in 2025, then advanced by 15.3% to -$23.1 million in 2026.
• The last three Change in Cash figures came in at -$23.1 million (Q1 2026), -$27.3 million (Q4 2025), and $14.4 million (Q3 2025), per Business Quant data.